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BACKGROUND. Previous reports have suggested an inverse relationship between smoking
and surgery for benign prostatic hyperplasia (BPH). We hypothesized that acute urinary
retention (AUR), an adverse outcome of this disease and indication for surgical treatment, may
be related to smoking.
METHODS. Study subjects were randomly selected from Olmsted County men aged 40–79
identified through the Rochester Epidemiology Project. Of the 3,854 eligible men, 2,089 (54%)
completed a questionnaire that included the American Urological Association Symptom Score
and assessed smoking status. Community medical records were examined for occurrence of
AUR with documented catheterization in the subsequent 10 years and occurrence of BPH
surgery. Proportional hazard models were used to assess the relationship between baseline
smoking status and subsequent retention.
RESULTS. In the 18,307 person-years of follow-up, 114 men had AUR. When compared to
727 never-smokers, there was a trend among the 336 current smokers to be at lower risk (Relative
risk (RR)¼ 0.62, 95% Confidence Interval (CI)¼ 0.33, 1.18) whereas the 1,026 former smokers
were at similar risk to non-smokers (RR¼ 1.0, 95%CI¼ 0.67, 1.46). Among men with moderate-
severe symptoms at baseline, current smokers were at lower risk of retention compared to non-
smokers (RR¼ 0.65, 95%CI¼ 0.22, 1.91) but the association approached the null among those
with none-mild symptoms (RR¼ 0.91, 95% CI¼ 0.40, 2.06).
CONCLUSIONS. Community-dwelling men who currently smoke may be at a modestly
reduced risk of AUR. The magnitude of this association is sufficiently small that it seems
unlikely that this explains a sizable proportion of the inverse association between smoking and
surgically treated BPH. Prostate 69: 699–705, 2009. # 2009 Wiley-Liss, Inc.
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INTRODUCTION
Previous reports have suggested an inverse relation-
ship between smoking and development of, or surgery
for, benign prostatic hyperplasia (BPH) [1–3]. There
has been a great deal of debate about whether or not this
represents a cause and effect relationship. In fact, many
have suggested that this inverse relationship may be
due to a bias imposed by smokers being perceived as
generally poorer surgical candidates, resulting in
proportionately fewer procedures among smokers as
compared to non-smokers [4,5]. However, smoking
could affect risk of BPH through either neurologic or
endocrine pathways [6]; either of these may affect a
man’s risk of acute urinary retention (AUR), often an
indicator of advanced disease and trigger for surgical
therapy [7,8]. We therefore hypothesized that an
inverse relationship between smoking and AUR may
be responsible for some portion of the inverse relation-
ship between smoking and surgery for BPH. Thus the
objective of this study was to test the hypothesis that
smoking status is inversely related to the incidence
of AUR. We accomplished this using data from a
prospective cohort study conducted in the context of
the Rochester Epidemiology Project (REP) [9].
MATERIALSANDMETHODS
Study Subjects
The Olmsted County Study of Urinary Symptoms
and Health Status among Men is a population-based,
prospective cohort study initiated in December of
1989 to study the natural history of BPH. Many of the
details of this study have been published previously
[10]. Briefly, this study was designed to measure
the age-specific prevalence of urinary symptoms in a
community-based sample of men and to follow these
men over time for the onset as well as progression or
regression of disease.
Potential subjects included men aged 40–79 years
who were residents of Olmsted County, Minnesota.
The resources of the REP [9] were used to establish a
sampling frame of Olmsted County residents. Men
aged 40–79 years on January 1, 1990 were randomly
selected within 5-year age groups and two geographic
strata (city of Rochester vs. balance of Olmsted County)
at a 14% sampling fraction. After screening a potential
subject’s medical history for exclusion and eligibility
criteria, he was contacted and his participation in the
study solicited. The exclusion criteria were established
to remove men who had previously received surgical
treatment for genitourinary conditions or had neuro-
logic conditions thought to interfere with normal
voiding. Of the 3,858 men identified as potentially
eligible for study, a total of 2,115 men (55%) completed
the study protocol at baseline which included com-
pletion of a previously validated self-administered
questionnaire [11] that included elements of lower
urinary tract symptoms, health status, and several
sociodemographic characteristics. Of the 2,115 men,
2089 (99%) provided baseline information regarding
smoking status and were included in the current
analysis.
Follow-Up
Medical records of all study subjects at virtually all
health care providers in Olmsted County were identi-
fied and reviewed. These records included information
on all physician visits in the inpatient or outpatient
settings, emergency room visits and home or nursing
home visits. Follow-up was conducted from July
1992 to February 1996 and again from March 2000 to
July 2002 by two trained nurse abstractors, providing a
median follow-up time of 105 months (8.75 years)
following completion of the baseline questionnaire.
The study protocol for the baseline and follow-up
investigations was approved by the Mayo Clinic
Foundation and Olmsted Medical Center Institutional
Review Boards.
Measurements
Twelve questions in the baseline questionnaire
elicited information regarding frequency of specific
urinary symptoms during the past month and were
measured on a 7-point scale from 0 (I do not have
symptoms) to 6 (always). A composite score for
symptom frequency was calculated to approximate
the American Urologic Association (AUA) symptom
index for BPH by re-scaling our data in consultation
with the AUA index developers [12]. Lower urinary
tract symptom severity was then categorized as none to
mild (AUASI 7) and moderate to severe (AUASI> 7).
Smoking status was assessed by questionnaire at
baseline. Men were categorized as ‘‘ever smokers’’ if
they had ever smoked a total of 100 or more cigarettes in
their lifetime, and ‘‘never smokers’’ if they had not.
Ever smokers were categorized as former or current
smokers based on their current smoking status.
Number of packs smoked per day and pack-years of
smoking were calculated for both former and current
smokers. Smoking exposure for smokers was based on
cigarette consumption at baseline and classified as light
(0–1 pack/day), moderate (1–1.4 packs/day), and
heavy (1.5 packs/day).
The occurrences of AUR and surgical BPH treatment
were ascertained through review of the complete
community medical records of each subject. A diag-
nosis of AUR was accepted only if there was
documentation of urinary bladder catheterization
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(transurethral or suprapubic) for acute retention. BPH
treatment included surgical and minimally invasive
procedures. For each subject the date of occurrence
for the first episode of acute retention and the date
of occurrence of the first surgical treatment were
recorded.
Statistical Analysis
The distribution of baseline variables was compared
by smoking status. The relative risk of AUR or surgical
treatment associated with baseline variables was
estimated using Cox proportional hazards models.
Follow-up started on the date the baseline question-
naire was completed, and continued until the first
occurrence of an event (AUR or surgical treatment) or
the date of death or last documented clinic visit
(censor). Models were constructed to estimate bivariate
associations between baseline characteristics and the
event, whereas multivariable models were constructed
to estimate relative risks after adjustment for other
baseline variables. Additional analyses were per-
formed with different cut points for the continuous
variables. These analyses yielded results of similar
direction and magnitude, and only the results based on
the above cut points are presented for simplicity. All
analyses were performed using SAS Version 8.2 (Cary,
NC).
RESULTS
Among the 2,089 men who participated in the study
at baseline and had smoking status available, 336 (16%)
reported being current smokers, 1,026 (49%) former
smokers, and 727 (35%) reported having never smoked.
(Table I) In addition, 1,391 of the 2,092 men with AUASI
information available (66%) reported none to mild
urinary symptoms at baseline and conversely 701 (34%)
reported moderate to severe symptoms (AUASI> 7).
During the 18,307 person-years of follow-up,
114 men developed AUR (Table II). Of the men who
never smoked, 5.9% developed AUR, as opposed to
only 3.6% of current smokers. When compared to the
726 never-smokers, there was a trend among the
333 current smokers to be at lower risk in crude
analyses (Relative risk (RR)¼ 0.62, 95% Confidence
Interval (CI)¼ 0.33, 1.18) whereas the 1,023 former
smokers were at similar risk to non-smokers (RR¼ 1.0,
95%CI¼ 0.67, 1.46).
The inverse association between smoking and AUR
strengthened in a dose-response fashion by pack-years
of smoking. Men who smoked for 1–20 years had an
age-adjusted RR of 0.96 [95% CI (0.61–1.51)], and men
who smoked more than 20 years had an age-adjusted
RR of 0.76 [95% CI (0.49–1.20)] (Table III).
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40–49 166 (49.4%) 323 (31.5%) 291 (40.0%)
50–59 91 (27.1%) 296 (28.9%) 218 (30.0%)
60–69 57 (17.0%) 246 (24.0%) 134 (18.4%)
70þ 22 (6.6%) 161 (15.7%) 84 (11.6%)
AUA symptom score
7 242 (71.8%) 669 (65.1%) 480 (65.9%)
>7 95 (28.2%) 358 (34.9%) 248 (34.1%)
Prostate volume
30 62 (75.6%) 173 (60.7%) 141 (65.0%)
>30 20 (24.4%) 112 (39.3%) 76 (35.0%)
Qmax
12 304 (90.5%) 801 (78.1%) 548 (75.5%)
<12 32 (9.5%) 225 (21.9%) 178 (24.5%)
Hypertension
No 286 (84.9%) 784 (77.0%) 586 (80.6%)
Yes 51 (15.1%) 234 (23.0%) 141 (19.4%)
Diabetes
No 323 (95.9%) 966 (94.1%) 698 (95.9%)
Yes 14 (4.2%) 61 (5.9%) 30 (4.1%)
TABLE II. Crude andAge-AdjustedAssociation of AcuteUrinary RetentionWith Baseline Smoking Status
Smoking
status
Acute urinary retention Relative risks
Yes No Crude Age-adjusted
na % na % RR 95% CI RR 95% CI
Never 43 5.9 683 94.1 1.0 — 1.0 —
Former 59 5.8 964 94.2 1.0 0.67–1.46 0.88 0.59–1.31
Current 12 3.6 321 96.4 0.62 0.33–1.18 0.78 0.41–1.49
RR, relative risk; CI, confidence interval.
aColumn totals do not add to 2,089 due to missing data.
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While current smokers also appeared to have a
decreased risk of surgical treatment in unadjusted
analyses (RR¼ 0.59, 95%CI¼ 0.34, 1.02) as compared to
never smokers, the results did not reach statistical
significance (Table IV). Former smokers were at a
similar risk to non-smokers (RR¼ 1.10, 95%CI¼ 0.79,
1.51). However, no dose-response trend with pack-
years of smoking was observed (Table V).
Among men with none to mild urinary symptoms at
baseline, both former and current smokers were some-
what less likely to develop AUR as compared to never
smokers, with age-adjusted RRs of 0.71 [95% CI (0.39–
1.28)] and 0.91 [95% CI (0.40–2.06)], respectively
(Table VI). Among men who reported moderate to
severe urinary symptoms at baseline, current smokers
had a decreased risk with an age-adjusted RR of
0.65 [95% CI (0.22–1.91)]. Former smokers, however,
were at similar risk compared to never smokers, with a
RR of 1.04 [95% CI (0.61–1.78)]. The test for interaction
between smoking status and symptom severity was not
significant (P¼ 0.33, data not shown).
Similarly, among men with none to mild urinary
symptoms at baseline, current smokers were less likely
undergo surgical treatment as compared to never
smokers, with an age-adjusted RR of 0.80 [95% CI
(0.36–1.80)] albeit these results were not statistically
significant (Table VII). Among men who reported
moderate to severe urinary symptoms at baseline,
current smokers had a decreased risk with an age-
adjusted RR of 0.71 [95% CI (0.33–1.52)]. While former
smokers with none to mild urinary symptoms at
baseline were at a slightly elevated risk of surgical
treatment as compared to never smokers (RR¼ 1.27,
95%CI¼ 0.78, 2.08) in age-adjusted analyses, former
smokers with moderate to severe symptoms were at
decreased risk of surgical treatment (RR¼ 0.76,
95%CI¼ 0.49, 1.17).
DISCUSSION
The objective of this study was to test the hypothesis
that smoking status is inversely related to the incidence
of AUR. Overall, these data demonstrate a trend
towards a lower risk of acute urinary retention among
current smokers as compared to never-smokers that
was not evident for former smokers. This inverse
association appeared to be more apparent among men
who reported greater lower urinary tract symptom
severity at baseline, who were at two-to-three times the
risk of AUR. The trend was similar by pack-years of
smoking at baseline.
In a previous study of this population we found
that AUR was associated with lower urinary tract
symptom severity. Overall, men with moderate to
The Prostate
TABLE III. Crude andAge-AdjustedAssociation ofAcuteUrinaryRetentionWith Pack-Years of Smoking at Baseline
Smoking (pack years)
Acute urinary retention Relative risks
Yes No Crude Age-adjusted
na % na % RR 95% CI RR 95% CI
0 43 5.9 684 94.1 1.0 — 1.0 —
1–20 34 5.4 596 94.6 0.92 0.59–1.44 0.96 0.61–1.51
>20 34 5.0 648 95.0 0.86 0.55–1.35 0.76 0.49–1.20
RR, relative risk; CI, confidence interval.
aColumn totals do not add to 2,089 due to missing data.
TABLE IV. Crude andAge-AdjustedAssociation of Surgical TreatmentWith Baseline Smoking Status
Smoking status
Surgery Relative risks
Yes No Crude Age-adjusted
na % na % RR 95% CI RR 95% CI
Never 74 10.0 665 90.0 1.0 — 1.0 —
Former 101 9.8 930 90.2 1.10 0.79–1.51 0.96 0.69–1.32
Current 18 5.4 317 94.6 0.59 0.34–1.02 0.70 0.40–1.21
RR, relative risk; CI, confidence interval.
aColumn totals do not add to 2,089 due to missing data.
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severe symptoms were at a threefold increased risk of
AUR compared to men with no to mild symptoms [13].
These results suggested that the cut point suggested for
considering treatment options for BPH in the Agency
for Health Care Policy and Research (AHCPR) diag-
nostic and treatment guidelines [14], provides some
level of discrimination between those who are more
likely to develop retention and those who do not. In this
same cohort, we found that compared to never
smokers, current smokers were less likely to have
moderate to severe urinary symptoms [15]. This has
been observed in other settings as well [16,17].
Consequently, if smokers are less likely to develop
moderate to severe LUTS, the risk for subsequent AUR
potentially decreases as suggested by the previous
study described above. This is supported by our
findings in the current report as we found smoking to
be inversely related to AUR and this inverse association
was enhanced in men who reported moderate to severe
LUTS.
In this community setting, men who currently
smoke may be at a modestly reduced risk of AUR.
The magnitude of this association is sufficiently small
that it seems unlikely that this explains a sizable
proportion of the inverse association between smoking
and surgically treated BPH. Nearly half of all episodes
of acute urinary retention in this cohort were associated
with surgical procedures, and nearly 90% of these were
performed with the patient under general anesthesia.
Only 14% of persons with an incident event sub-
sequently underwent transurethral resection of the
prostate and only 1 subject experienced subsequent
episodes of retention. While the number of cases is
small, these data suggest that some factor associated
with general anesthesia, either pharmacological, phys-
iological or traumatic, may have a precipitating role in a
large proportion of cases of AUR in the community.
When interpreting these data, several potential
limitations must be considered. Follow-up was limited
to the information recorded in the community medical
records. However, AUR is a condition that is likely to
come to medical attention and recorded in the medical
records, even if not assigned a diagnostic code. In
addition, prior studies have observed that patterns of
tobacco use tend to be under-reported [18,19]. The
small percentage of smokers (16%) in this study
appears disproportionately low and may imply a
non-representative study sample, misclassification of
The Prostate
TABLE V. Crude andAge-AdjustedAssociation of Surgical TreatmentWith Pack-Years of Smoking at Baseline
Smoking (pack years)
Surgery Relative risks
Yes No Crude Age-adjusted
na % na % RR 95% CI RR 95% CI
0 74 10.0 666 90.0 1.0 — 1.0 —
1–20 49 7.8 583 92.2 0.89 0.61–1.31 0.91 0.62–1.34
>20 69 10.0 621 90.0 1.10 0.77–1.56 0.94 0.66–1.34
RR, relative risk; CI, confidence interval.
aColumn totals do not add to 2,089 due to missing data.












RR 95% CI RR 95% CI RR 95% CI RR 95% CI
Never 22 (4.6) 1.0 — 1.0 — 21 (8.5) 1.0 — 1.0 —
Former 23 (3.4) 0.75 0.42–1.34 0.71 0.39–1.28 36 (5.2) 1.23 0.72–2.11 1.04 0.61–1.78
Current 8 (0.6) 0.74 0.33–1.66 0.91 0.40–2.06 4 (0.6) 0.53 0.18–1.54 0.65 0.22–1.91
RR, relative risk; CI, confidence interval.
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exposure or low smoking rates in the source popula-
tion. It is unlikely, however, that any of these potential
biases are related to retention status; therefore
estimates of the associations between smoking and
AUR would most likely be unaffected or biased
towards the null. Furthermore, smoking was assessed
in this study at baseline and thus does not reflect
changes in smoking over the course of the study. In
addition, the associations suggest an inverse relation-
ship between smoking and AUR but the interval
estimates included the null hypotheses and therefore
the results could have occurred by chance alone. Even if
the association is real, the apparent effect of cigarette
smoking may be due to some other unhealthy
behavior/risk factor not measured.
Finally, there may be limitations to the general-
izability of these findings. Residents of Olmsted
County tend to be well insured [9] which could lead
to the opportunity for earlier intervention that might
prevent later complications such as AUR. Furthermore,
the effects of being included in this study may increase
subject awareness, increase the opportunity for inter-
vention and, thereby, decrease the chance of these late
complications. In balance, the local practice has
been viewed as conservative, probably because of the
proximity to healthcare providers and ability to
intervene in emergency situations. In fact, transurethral
resection of the prostate rates for Olmsted County have
traditionally been lower than for the rest of the country
[20]. Along these same lines, the initial participation
rate and baseline exclusion criteria may have influ-
enced the generalizability of the findings. However, in
a previous study, we found little difference in rates of
AUR between participants and non-participants [13].
This suggests that slight systematic differences in
baseline composition of the cohort may not have had
as great an influence in subsequent follow-up. Finally,
because these results are based on white men,
extrapolation of findings to other races or settings
may not be appropriate.
CONCLUSIONS
In a community setting, men who currently smoke
may be at a modestly reduced risk of acute
urinary retention. The magnitude of this association is
sufficiently small that it seems unlikely that this
explains a sizable proportion of the inverse association
between smoking and surgically treated BPH.
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